Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views

By D. Phinney, D. Prockop. Stem Cells, 2007

1,971 citations recorded by the source corpus.

Subfields: Genetics, Rehabilitation, Surgery

View Paper: https://www.semanticscholar.org/paper/640a02b6a4da07efad019149ebfdc2d545cf40a5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. J. Karp
2. Grace Sock Leng Teo
3. P. Robey
4. P. Bianco
5. M. Roy
6. A. Bandyopadhyay
7. Andrea Augello
8. C. De Bari

In Rehabilitation

1. M. Roy
2. A. Bandyopadhyay
3. Andrea Augello
4. C. De Bari
5. J. Karp
6. S. Bose
7. Grace Sock Leng Teo

In Surgery

1. J. Karp
2. Grace Sock Leng Teo
3. M. Roy
4. A. Bandyopadhyay
5. Andrea Augello
6. C. De Bari
7. S. Bose

Citations in the corpus

• The Regulation of Differentiation in Mesenchymal Stem Cells (2010, positive): “, 2007), although even within each tissue source, single-cell-derived clonal MSC populations are highly heterogeneous in their proliferative and differentiation potentials (Phinney and Prockop, 2007; De Bari et al., 2008).”
• Mesenchymal stem cell homing: the devil is in the details. (2009, positive): “…to regenerate damaged tissue and treat inflammation resulting from cardiovascular disease and myocardial infarction (MI), brain and spinal cord injury, cartilage and bone injury, Crohn’s disease, and graft-versus-host disease (GVHD) during bone marrow transplantation (Phinney and Prockop, 2007).”
• Recent advances in bone tissue engineering scaffolds (2012, methodology): “Human umbilical cord mesenchymal stem cells (hUCMSC) multipotent cell line capable of differentiating in to osteoblasts, chondrocytes, and adipocytic cells [20]”
• Mesenchymal stem cells: revisiting history, concepts, and assays. (2008, background): “…for the ability of transplanted BMSCs to generate differentiated nonskeletal tissue cell types (e.g., cardiomyocytes, neurons, etc.) has been controversial, a beneficial effect on the function of target organs has often been observed (reviewed in Phinney and Prockop, 2007; Picinich et al., 2007).”
• Same or Not the Same? Comparison of Adipose Tissue-Derived Versus Bone Marrow-Derived Mesenchymal Stem and Stromal Cells (2012, neutral): “There are several additional immunophenotypic markers (such as CD29, CD44, CD146, CD166, CD271, etc.) that can be used to characterize the MSC populations obtained from various sources [11,21,22].”
• Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. (2009, background): “In equation (1), yij is the observed expression level for transcript i in sample j (j 1,.”